Red, take a chill pill. Same day as UNIS announces a major contract with Sanofi(15 years. Sanofi and "Ren"), you are down ramping, with articles from The Street. You wonder way it is not up 88%, i think that this i the first of many. We have active programs coming for all devices not just the pumps? Last Quarter we had 12 Active Customer Programs, i can only count 5 announced. Hikma, Sanofi x2, MedImmune, Novarits.
I would like to see who the active program is for the Ocu-Ject is with, We know Sanofi just doesn't jump into bed with us without doing a hell of a lot of DD. The wording the pump contract points the finger at REN, and PCSK9. So i would be hoping that REN is looking at Oct-Ject for Eyelea. Just IMHO.
UNS Price at posting:
41.5¢ Sentiment: Buy Disclosure: Held